SHIMODAIRA Shigetaka

FacultyDepartment of Regenerative Medicine, Regenerative Medicine Center, Department of Advanced Medicine
PositionProfessor

Researcher Profile & Settings

Degree

  • Ph.D in Medicine

Research Activities

Published Papers

  • Impact of mature dendritic cells pulsed with a novel WT1 helper peptide on the induction of HLA‑A2‑restricted WT1‑reactive CD8+ T cells, Kan S, Bito T, Shimabuku M, Taguchi J, Ohkusa T, Shimodaira S, Sugiyama H, Koido S, International Journal of Oncology57:1047-1056Oct. 2020
  • Impact of mature dendritic cells pulsed with a novel WT1 helper peptide on the induction of HLA-A2-restricted WT1-reactive CD8(+) T cells, Kan, Shin;Bito, Tsuuse;Shimabuku, Masamori;Taguchi, Junichi;Ohkusa, Toshifumi;Shimodaira, Shigetaka;Sugiyama, Haruo;Koido, Shigeo, INTERNATIONAL JOURNAL OF ONCOLOGY57:1047-1056Oct. 2020
  • Complete measurable residual disease response after combination chemotherapy with AML-type and ALL-type regimens in pediatric B/myeloid acute bilineal leukemia, (Shoji Saito), Chiaki Taira, Kazuyuki Matsuda, Ryu Yanagisawa, Daisuke Morita, Tomonari Shigemura, Kentaro Yoshikawa, Miyuki Tanaka, Kazuo Sakashita, Saki Mukai, Shigetaka Shimodaira, Kenichi Koike, Yozo Nakazawa, Leukemia & Lymphoma61:967-970Apr. 2020
  • Dendritic Cells Pre-Pulsed with Wilms' Tumor 1 in Optimized Culture for Cancer Vaccination, Koya, Terutsugu;Date, Ippei;Kawaguchi, Haruhiko;Watanabe, Asuka;Sakamoto, Takuya;Togi, Misa;Kato, Tomohisa;Yoshida, Kenichi;Kojima, Shunsuke;Yanagisawa, Ryu;Koido, Shigeo;Sugiyama, Haruo;Shimodaira, Shigetaka, PHARMACEUTICS12Apr. 2020
  • Dendritic Cells Pre-Pulsed With Wilms' Tumor 1 in Optimized Culture for Cancer Vaccination, Terutsugu Koya, Ippei Date, Haruhiko Kawaguchi, Asuka Watanabe, Takuya Sakamoto, Misa Togi, Tomohisa Kato Jr, Kenichi Yoshida, Shunsuke Kojima, Ryu Yanagisawa, Shigeo Koido, Haruo Sugiyama , Shigetaka Shimodaira, Pharmaceutics12:305Mar. 2020
  • Dendritic Cells Pre-Pulsed with Wilms' Tumor 1 in Optimized Culture for Cancer Vaccination., Koya Terutsugu;Date Ippei;Kawaguchi Haruhiko;Watanabe Asuka;Sakamoto Takuya;Togi Misa;Kato Tomohisa;Yoshida Kenichi;Kojima Shunsuke;Yanagisawa Ryu;Koido Shigeo;Sugiyama Haruo;Shimodaira Shigetaka, Pharmaceutics122020
  • Investigation of factors associated with allergic transfusion reaction due to platelet transfusion and the efficacy of platelets resuspended in BRS‐A in adult patients, (Manjiro Yamanaka), Ryu Tanagisawa, Shunsuke Kojima, Hideyuki Nakazawa, Shigetaka Shimodaira, Transfusion59:3405-3412Dec. 2019
  • Predicted Markers of Overall Survival in Pancreatic Cancer Patients Receiving Dendritic Cell Vaccinations Targeting WT1, (Ito Z), Kan S, Bito T, Horiuchi S, Akasu T, Yoshida S, Kajihara M, Hokari A, Saruta M, Yoshida N, Kobayashi M, Ohkusa T, Shimodaira S, Okamoto M, Sugiyama H, Koido S, Oncology97:135-148Sep. 2019
  • In Vivo Administration of Recombinant Human Granulocyte Colony-Stimulating Factor Increases the Immune Effectiveness of Dendritic Cell-Based Cancer Vaccination, Shimodaira S, Yanagisawa R, Koya T, Hirabayashi K, Higuchi Y, Sakamoto T, Togi M, Kato T Jr, Kobayashi T, Koizumi T, Koido S, Sugiyama H, Vaccines (Basel)7:120Sep. 2019
  • Comparison of administration of platelet concentrates suspended in M-sol or BRS-A for pediatric patients, (Shunsuke Kojima), Ryu Yanagisawa, Miyuki Tanaka, Yozo Nakazawa, Shigetaka Shimodaira, TRANSFUSION58:2952-2958Dec. 2018
  • Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma, (Tomoya Kanai), Zensho Ito, Yusuke Oji, Machi Suka, Sumiyuki Nishida, Kazuki Takakura, Mikio Kajihara, Masayuki Saruta, Shuichi Fujioka, Takeyuki Misawa, Tadashi Akiba, Hiroyuki Yanagisawa, Shigetaka Shimodaira, Masato Okamoto, Haruo Sugiyama, Shigeo Koido, Oncology Letters16:2682-2692Aug. 2018
  • WT1-pulsed Dendritic Cell Vaccine Combined with Chemotherapy for Resected Pancreatic Cancer in a Phase I Study, (Yanagisawa R), Koizumi T, Koya T, Sano K, Koido S, Nagai K, Kobayashi M, Okamoto M, Sugiyama H, Shimodaira S, ANTICANCER RESEARCH38:2217-2225Apr. 2018
  • Feasibility and Immune Response of WT1 Peptide Vaccination in Combination with OK-432 for Paediatric Solid Tumors, (Hirabayashi K), Yanagisawa R, Saito S, Higuchi Y, Koya T, Sano K, Koido S, Okamoto M, Sugiyama H, Nakazawa Y, Shimodaira S, ANTICANCER RESEARCH38:2227-2234Apr. 2018
  • Evaluation of Gelatin-Hybridized Chelate-Setting Calcium Phosphate Cements in Alveolar Bone Defects of Canine Mandible, Goichi Matsumoto, Yoshihiko Sugita, Katsutoshi Kubo, Waka Yoshida, Hatsuhiko Maeda, Mamoru Aizawa, Shigetaka Shimodaira, Yukihiko Kinoshita, Biomedical Journal of Scientific & Technical Research3:3420-3426Apr. 2018
  • Administration of platelet concentrates suspended in bicarbonated Ringer's solution in children who had platelet transfusion reactions, (Kobayashi J), Yanagisawa R, Ono T, Tatsuzawa Y, Tokutake Y, Kubota N, Hidaka E, Sakashita K, Kojima S, Shimodaira S, Nakamura T, VOX SANGUINIS113:128-135Feb. 2018
  • Significance of Wilms tumor 1 antigen as a canser vaccine for pancreatic cancer, Koido.S, Okamoto.M ,Kobayashi.M, Shimodaira.S, Sugiyama.H, Discovery Medicine130:41-49Aug. 2017
  • Interferon-α-inducible Dendritic Cells Matured with OK-432 Exhibit TRAIL and Fas LIgand Pathway-mediated Killer Activity, Terutsugu Koya,Ryu Yanagisawa,Yumiko Higuchi,Kenji Sano&Shigetaka Shimodaira, SCIENTIFIC REPORTS7:42145Feb. 2017
  • Interferon-α-inducible Dendritic Cells Matured with OK-432 Exhibit TRAIL and Fas Ligand Pathwaymediated Killer Activity, (T.Koya), R.Yanagisawa, Y. Higuchi, K.Sano, S.Shimodaira, Scientific Reports3:1-4Feb. 2017
  • Clinical effect and immunological response in patients with advanced malignant glioma treated with WT1-pulsed dendritic cell-based immunotherapy: A report of two cases., Sakai K, Shimodaira S, Maejima S, Sano K, Higuchi Y, Koya T, Sugiyama H, Hongo K., Interdisciplinary Neurosurgery9:24-292017
  • WT1 Peptide Vaccine is Unaffected by Airport Screening X-Irradiation, (Y.Higuchi), M.Kawakubo, M.Yuzawa, K.Sano, S.Shimodaira, Austin Journal of Vaccines & Immunotherapeutics3:1010-1010Sep. 2016
  • Predictive factors of poor blood collecting flow during leukocyte apheresis for cellular therapy, (Saori Konno), Ryu Yanagisawa, Noriko Motoki, Shigetaka Shimodaira, Therapeutic Apheresis and Dialysis25:1001-1011Feb. 2021
  • Quality Verification with a Cluster-Controlled Manufacturing System to Generate Monocyte-Derived Dendritic Cells, Haruhiko Kawaguchi, Takuya Sakamoto, Terutsugu Koya, Misa Togi, Ippei Date, Asuka Watanabe, Kenichi Yoshida, Tomohisa Kato, Yuka Nakamura, Yasuhito Ishigaki, Shigetaka Shimodaira, Vaccines9:533May 2021
  • Identification of CD56 dim subpopulation marked with high expression of GZMB/PRF1/PI-9 in CD56 + interferon-α-induced dendritic cells, Asuka Watanabe, Misa Togi, Terutsugu Koya, Makoto Taniguchi , Takuya Sakamoto, Kuniyoshi Iwabuchi, Tomohisa Kato, Shigetaka Shimodaira, Genes to cells26:313-327May 2021
  • Interferon-α-Induced Dendritic Cells Generated with Human Platelet Lysate Exhibit Elevated Antigen Presenting Ability to Cytotoxic T Lymphocytes, Date I, Koya T, Sakamoto T, Togi M, Kawaguchi H, Watanabe A, Kato T Jr, Shimodaira S, Vaccines9:102021
  • The Detection of Immunity against WT1 and SMAD4P130L of EpCAM+ Cancer Cells in Malignant Pleural Effusion, Terutsugu Koya, Yo Niida, Misa Togi, Kenichi Yoshida, Takuya Sakamoto, Hiroki Ura, Sumihito Togi, Tomohisa Kato Jr, Sohsuke Yamada, Haruo Sugiyama, Shigeo Koido, Shigetaka Shimodaira, International Journal of Molecular Sciences23:12177Oct. 2022
  • Evaluation of the usefulness of human adipose-derived stem cell spheroids formed using SphereRing® and the lethal damage sensitivity to synovial fluid in vitro, Atsushi Fuku, Yasuhiko Taki, Yuka Nakamura, Hironori Kitajima, Takashi Takaki, Terutsugu Koya, Ikuhiro Tanida, Kaori Nozaki, Hiroshi Sunami, Hiroaki Hirata, Yoshiyuki Tachi, Togen Masauji, Naoki Yamamoto, Yasuhito Ishigaki, Shigetaka Shimodaira, Yusuke Shimizu, Toru Ichiseki, Ayumi Kaneuji, Satoshi Osawa, Norio Kawahara, Cells11:337Jan. 2022
  • A morphological study of adipose-derived stem cell sheets created with temperature-responsive culture dishes using scanning electron microscopy, Yasuhiko Taki, Atsushi Fuku, Yuka Nakamura, Terutsugu Koya, Hironori Kitajima, Ikuhiro Tanida, Takashi Takaki, Kaori Nozaki, Hiroshi Sunami, Hiroaki Hirata, Yoshiyuki Tachi, Takeo Shimasaki, Togen Masauji, Naoki Yamamoto, Yasuhito Ishigaki, Shigetaka Shimodaira, Yusuke Shimizu, Toru Ichiseki, Ayumi Kaneuji, Satoshi Osawa, Norio Kawahara, Medical Molecular Morphology55:187-198Sep. 2022
  • Certificate of acceptance for the manuscript (ijms-1913863) titled: Adaptive immunity against WT1 and SMAD4P130L of EpCAM+ cancer cells in malignant pleural effusion23:12177Oct. 2022
  • Analysis of Clinical Factors Associated with the Occurrence Time of AllergicTransfusion Reactions or Febrile Non-HemolyticTransfusion Reactions., (Yanagisawa R), Yamanaka R, Shimodaira S, Annals of Clinical & Laboratory Science52:382-390May 2022
  • Different in vitro-generated MUTZ-3-derived dendritic cell types secrete dexosomes with distinct phenotypes and antigen presentation potencies., Sakamoto T, Koya T, Togi M, Yoshida K, Kato T Jr, Ishigaki Y, Shimodaira S., International Journal of Molecular Sciences11:8362Jul. 2022
  • Synovial fluid derived from human knee osteoarthritis increases the viability of human adipose-derived stem cells through upregulation of FOSL1, Hironori Kitajima, Takuya Sakamoto, Tetsuhiro Horie, Ayane Kuwano, Atsushi Fuku, Yasuhiko Taki, Yuka Nakamura, Ikuhiro Tanida, Hiroshi Sunami, Hiroaki Hirata, Yoshiyuki Tachi, Naoki Yamamoto, Yasuo Iida, Yasuhito Ishigaki, Sohsuke Yamada, Shigetaka Shimodaira, Yusuke Shimizu, Toru Ichiseki, Ayumi Kaneuji, Satoshi Osawa and Norio Kawahara, Cells12:330Jan. 2023
  • An optimized cocktail of small molecule inhibitors promotes the maturation of dendritic cells in GM-CSF mouse bone marrow culture., Shintaro Matsuba, Hiroki Ura, Fumiji Saito, Chie Ogasawara, Shigetaka Shimodaira, Yo Niida, Nobuyuki Onai, Frontiers in Immunology14:1264609Oct. 2023
  • Clinical Trial on the Safety and Tolerability of Personalized Cancer Vaccines Using Human Platelet Lysate-Induced Antigen-Presenting Cells, Terutsugu Koya, Kenichi Yoshida, Misa Togi, Yo Niida, Sumihito Togi, Hiroki Ura, Shuichi Mizuta, Tomohisa Kato Jr, Sohsuke Yamada, Takeo Shibata, Yi-Chang Liu, Shyng-Shiou Yuan, Deng-Chyang Wu, Hirohito Kobayashi, Taiju Utsugisawa, Hitoshi Kanno, Shigetaka Shimodaira, Cancers15:3627Jul. 2023